Home Business News China strengthens COVID-19 vaccination, review of different visa policies According to Reuters

China strengthens COVID-19 vaccination, review of different visa policies According to Reuters


© Reuters. FILE PHOTO: A woman holds a small bottle labeled “Coronavirus COVID-19 Vaccine” and a medical syringe in front of the Chinese flag shown in this illustration.

BEIJING (Reuters) – China has accelerated its immunization against COVID-19, injected 10 million doses in about a week and is reviewing different visa policies based on vaccination status and virus in countries. Different officials, the officials said on Sunday.

Health Commission spokesperson Mi Feng said the country had administered 74.96 million doses of vaccine as of Saturday. That number increased from 64.98 million on March 14.

According to state media and a top health adviser, China aims to vaccinate 40% of its 1.4 billion people by mid-year. China was one of the first countries to start using the vaccine last year and has exported millions of doses, but its vaccination rates have dropped compared to countries like Israel and the United States.

A company spokesperson said during the press conference said more than 70 million injections of Sinovac Biotech were administered globally, without specifying how many of them were administered in China.

Beijing is looking at different policies for visa issuance, flights and number control to China based on vaccination progress and COVID-19 situation in different countries.

Feng Zijian, deputy director of the China Centers for Disease Control and Prevention (China CDC), said: “We do not exempt vaccinated people from current testing and quarantine measures. in.

However, he said China will pay attention to international progress in developing a “vaccine passport” and may adjust virus curbing measures once the domestic population reaches immunization levels. high.

Mao Junfeng, an official from the Ministry of Industry and Information Technology, said that China’s full-year vaccine production can fully satisfy the country’s needs.

The raw materials for the vaccine production, including glass vials and syringes, were “relatively stable,” he said.

Wu Zunyou, head of the epidemiological group at CDC China, said countries with a high proportion of the elderly should be given priority to be vaccinated.

Wu explained at the China Development Forum in Beijing on Saturday night, if all the countries were pushing their vaccination programs at the same rate, it could be 10% or 30% each. Immunity, not enough to protect population.

“We need to get 70% -80% in one country as soon as possible, then the second country, then the third country,” Wu said.

China has approved four domestically produced vaccines for general public use from Sinovac, CanSino Biologics and two units of China National Pharmaceutical Corporation (Sinopharm).

A fifth vaccine developed by the Institute of Microbiology of the Chinese Academy of Sciences was approved for emergency use last week.

Disclaimer: Fusion Media wants to remind you that the data contained in this website is not necessarily real-time nor is it accurate. All CFDs (stocks, indices, futures) and forex prices are not provided by exchanges but are provided by the market makers, so the prices may be inaccurate and may differ from actual market price, which means that price is indicative only and not suitable for trading purposes. Consequently, Fusion Media accepts no liability whatsoever for any transaction losses you may incur as a result of using this data.

Fusion Media or anyone associated with Fusion Media will not be liable in any way for loss or damage resulting from dependence on information including data, quotes, charts and buy / sell signals contained in the this site. Please be fully informed about the risks and costs associated with trading the financial markets, which is one of the riskiest investments possible.



RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Recent Comments